CDXS
CDXS
NASDAQ · Life Sciences Tools & Services

Codexis Inc

$1.08
+0.06 (+5.88%)
Financial Highlights (FY 2026)
Revenue
83.53M
Net Income
-52,186,799
Gross Margin
86.7%
Profit Margin
-62.5%
Rev Growth
-20.2%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 83.53M 104.71M 48.43M 53.29M
Gross Profit 72.45M 90.81M 26.58M 29.25M
Operating Income -49,535,686 -55,881,320 7.30M 7.53M
Net Income -52,186,799 -58,872,047 5.77M 5.06M
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Rev Growth -20.2% -20.2% +4.8% -3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 24.71M 24.71M 36.68M 34.44M
Total Equity 31.14M 31.14M 50.40M 46.39M
D/E Ratio 0.79 0.79 0.73 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -43,488,999 -51,785,596 7.56M 9.74M
Free Cash Flow — — 6.31M 7.69M